161 related articles for article (PubMed ID: 24751795)
1. Viability of long-term gene therapy in the cochlea.
Atkinson PJ; Wise AK; Flynn BO; Nayagam BA; Richardson RT
Sci Rep; 2014 Apr; 4():4733. PubMed ID: 24751795
[TBL] [Abstract][Full Text] [Related]
2. The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection.
Wise AK; Tu T; Atkinson PJ; Flynn BO; Sgro BE; Hume C; O'Leary SJ; Shepherd RK; Richardson RT
Hear Res; 2011 Aug; 278(1-2):69-76. PubMed ID: 21557994
[TBL] [Abstract][Full Text] [Related]
3. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.
Wise AK; Hume CR; Flynn BO; Jeelall YS; Suhr CL; Sgro BE; O'Leary SJ; Shepherd RK; Richardson RT
Mol Ther; 2010 Jun; 18(6):1111-22. PubMed ID: 20216530
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin gene therapy for sustained neural preservation after deafness.
Atkinson PJ; Wise AK; Flynn BO; Nayagam BA; Hume CR; O'Leary SJ; Shepherd RK; Richardson RT
PLoS One; 2012; 7(12):e52338. PubMed ID: 23284995
[TBL] [Abstract][Full Text] [Related]
5. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro.
Pettingill LN; Minter RL; Shepherd RK
Neuroscience; 2008 Mar; 152(3):821-8. PubMed ID: 18304740
[TBL] [Abstract][Full Text] [Related]
6. Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy.
Takada Y; Beyer LA; Swiderski DL; O'Neal AL; Prieskorn DM; Shivatzki S; Avraham KB; Raphael Y
Hear Res; 2014 Mar; 309():124-35. PubMed ID: 24333301
[TBL] [Abstract][Full Text] [Related]
7. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
Rejali D; Lee VA; Abrashkin KA; Humayun N; Swiderski DL; Raphael Y
Hear Res; 2007 Jun; 228(1-2):180-7. PubMed ID: 17416474
[TBL] [Abstract][Full Text] [Related]
8. AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.
Leake PA; Rebscher SJ; Dore' C; Akil O
J Assoc Res Otolaryngol; 2019 Aug; 20(4):341-361. PubMed ID: 31222416
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness.
Leake PA; Akil O; Lang H
Hear Res; 2020 Sep; 394():107955. PubMed ID: 32331858
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of AAV.BDNF and AAV.Ntf3 in the deafened adult guinea pig ear.
Budenz CL; Wong HT; Swiderski DL; Shibata SB; Pfingst BE; Raphael Y
Sci Rep; 2015 Mar; 5():8619. PubMed ID: 25726967
[TBL] [Abstract][Full Text] [Related]
11. Development of a cell-based treatment for long-term neurotrophin expression and spiral ganglion neuron survival.
Zanin MP; Hellström M; Shepherd RK; Harvey AR; Gillespie LN
Neuroscience; 2014 Sep; 277():690-9. PubMed ID: 25088914
[TBL] [Abstract][Full Text] [Related]
12. Green fluorescent protein as a reporter for gene transfer studies in the cochlea.
Lalwani AK; Han JJ; Walsh BJ; Zolotukhin S; Muzyczka N; Mhatre AN
Hear Res; 1997 Dec; 114(1-2):139-47. PubMed ID: 9447928
[TBL] [Abstract][Full Text] [Related]
13. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.
Wise AK; Richardson R; Hardman J; Clark G; O'leary S
J Comp Neurol; 2005 Jun; 487(2):147-65. PubMed ID: 15880560
[TBL] [Abstract][Full Text] [Related]
14. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
Luebke AE; Foster PK; Muller CD; Peel AL
Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult.
Lalwani AK; Han JJ; Castelein CM; Carvalho GJ; Mhatre AN
Laryngoscope; 2002 Aug; 112(8 Pt 1):1325-34. PubMed ID: 12172239
[TBL] [Abstract][Full Text] [Related]
16. [Adenovirus-mediated NT3 gene transfer protects spiral ganglion neurons from degeneration after noise trauma].
Chen Q; Guo WW; Wu Y; Liu H; Zhai SQ; Wang JZ; Fan M
Sheng Li Xue Bao; 2002 Jun; 54(3):263-6. PubMed ID: 12075476
[TBL] [Abstract][Full Text] [Related]
17. Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea.
Wise AK; Tan J; Wang Y; Caruso F; Shepherd RK
PLoS One; 2016; 11(10):e0164867. PubMed ID: 27788219
[TBL] [Abstract][Full Text] [Related]
18. Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.
Akil O; Blits B; Lustig LR; Leake PA
Hum Gene Ther; 2019 Jan; 30(1):88-105. PubMed ID: 30183384
[TBL] [Abstract][Full Text] [Related]
19. Viral vector tropism for supporting cells in the developing murine cochlea.
Sheffield AM; Gubbels SP; Hildebrand MS; Newton SS; Chiorini JA; Di Pasquale G; Smith RJ
Hear Res; 2011 Jul; 277(1-2):28-36. PubMed ID: 21530627
[TBL] [Abstract][Full Text] [Related]
20. Hair cell regeneration after ATOH1 gene therapy in the cochlea of profoundly deaf adult guinea pigs.
Atkinson PJ; Wise AK; Flynn BO; Nayagam BA; Richardson RT
PLoS One; 2014; 9(7):e102077. PubMed ID: 25036727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
